Cholesterol Risk Table

Borderline High
Total Cholesterol
Less than 200 mg/dL200-239 mg/dL>240 mg/dL
Greater than 45 mg/dL20 - 45 mg/dL<20 mg/dL
Less than 130 mg/dL130-159 mg/dL>160 mg/dL
Less than 150 mg/dL150-400 mg/dL>400 mg/dL

* Less than 40 mg/dL creates additional risk
**Less than 100 mg/dL optimally if you have had a previous heart attack or stroke

Since 1984, 3 major studies have shown thatcholesterol plays a significant role in Coronary Heart Disease (CHD) andthat lowering cholesterol to acceptable levels significantly reducesthe risk of developing CHD.The same study showed that small butsignificant increases in HDL are associated with additional reduction inCHD risk.Increasingly, the measurement of HDL is being used as anindicator of risk and may be a strong predictor of risk, especially inwomen and older individuals.Elevated triglycerides may also be a riskfactor for CHD.When performed as part of a Lipid Profile, Totalcholesterol, HDL and Triglycerides are used in the calculation of anestimated LDL value.The National Institute of Health has recommendedaggressive efforts to identify and treat those at risk for CHD.

High blood cholesterol is a condition thatgreatly increases your chances of developing CHD, the main form of heartdisease.That is because extra cholesterol in the blood collects inthe inner walls of the arteries, allowing less blood to get to theheart.

The primary evidence to support cholesterolscreening is the ability of cholesterol-lowering interventions toreduce the risk of CHD in patients with high cholesterol.Thesebenefits are now well established for persons with preexistingarteriosclerotic vascular disease.In individual trials and overviewsof studies enrolling persons with angina or prior to myocardialinfarction, cholesterol-lowering treatments slowed the progression ofatherosclerosis, reduced the incidence of CHD, and reduced overallmortality.

Recommendation: Periodic screening for high blood cholesterol is recommended for allmen and women.The National Cholesterol Education Program AdultTreatment Panel II, convened by the National Heart, Lung and BloodInstitute, recommends routine measurement of nonfasting totalcholesterol and HDL in all adults age 20 or older.Screening youngpersons can provide other information to help stimulate lifestylechanges.Elevated cholesterol is an important risk factor for CHD inmen and women in the U.S. and there is now good evidence that loweringcholesterol can reduce the risk of CHD.Measures that lower cholesteroland provide other health benefits (e.g. regular physical activity,reducing dietary fat, and maintaining a healthy weight) should beencouraged in all persons.Cholesterol screening can identify high-riskindividuals who are most likely to benefit from individualizedcounseling.